Skip to main content
. Author manuscript; available in PMC: 2020 Nov 7.
Published in final edited form as: Int J Dermatol. 2020 Feb 28;59(9):1033–1042. doi: 10.1111/ijd.14824

Table 2.

Number of human studies about the association between urinary concentration of oxybenzone (BP-3) or octinoxate (OMC) and the physiological outcomes. n=16 (duplicate excluded)

Target effect Statistically significant
association
No statistically significant
association
BP-3 OMC BP-3 OMC
Thyroid hormone level 2 (↓↓) 0 3 1a
Pubertal onset 2 (↓↑) 0 0 0
Male reproductive hormone level 1 (↓) 0 1 1a
Female reproductive hormone level 0 0 2 1a
Kidney function 1 (↓) 0 0 0
Fertility 0 0 4 0
Childhood adiposity 0 0 1 0

In parenthesis, ↓ indicates a negative correlation with elevated BP-3 level. ↑ indicates a positive correlation with elevated BP-3 level.

a

The results are from the same paper that is also included in BP-3 column.